Vanguardia, Khinn Luiz Roi C.

HRN: 23-83-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
02/26/2025
03/06/2025
TOPICAL
Apply Copiusly
Bid
Burn
Waiting Final Action 
02/26/2025
CEFUROXIME 750MG (VIAL)
02/26/2025
03/05/2025
IV
375mg
Q8
Burn
Waiting Final Action 
03/02/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/02/2025
03/09/2025
TOPICAL
25g
BID
Superficial Partial Thickness Burn 9% TBSA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: